the invention relates to substituted heterocycle fused gamma - carbolines of the formula q as described herein , in free base or pharmaceutically acceptable salt form , and / or pharmaceutical compositions thereof , and methods of use in the treatment of diseases involving the 5 - ht 2a receptor pathway , the serotonin transporter pathway and / or the dopamine d 2 receptor pathway signaling systems .